<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-058472</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Cystatin C and other cardiovascular markers in hypertension</dc:title>
<dc:description xml:lang="en">Background and objective: The aim of the study was to assess the relationship of cystatine C to other cardiovascular risk factors in hypertension. Patients and method: Cross-sectional study in hypertensive outpatients with normal creatinine values (= 30 mg/24 h, were independent factors related to the presence of high levels (&gt; 0.76 mg/l) of cystatine C in a logistic regression analysis. 58% of patients with UAE &gt;= 30 mg/24h had cystatin C values &lt; 0,76 mg/l. Conclusions: In hypertensive patients, the GFR is the most important factor related to cystatine C values. Increased levels of cystatine C do not correspond to UAE augmentation</dc:description>
<dc:creator>Amparo Miralles, Amparo</dc:creator>
<dc:creator>Pérez Lahiguera, Francisco</dc:creator>
<dc:creator>Costa, José A</dc:creator>
<dc:creator>Pascual, José M</dc:creator>
<dc:creator>Rodilla, Enrique</dc:creator>
<dc:creator>González, Carmen</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Fundamento y objetivo: Valorar la relación entre la cistatina C y otros parámetros bioquímicos establecidos como marcadores de riesgo vascular (RV) en pacientes hipertensos. Pacientes y método: Estudio descriptivo transversal de pacientes hipertensos de edad &gt; 18 años, creatinina = 30 mg/24 h, incrementaban de forma significativa e independiente la probabilidad de presentar valores elevados de cistatina. En los pacientes con EUA &gt;= 30 mg/24 h, el 58% tenía valores de cistatina &lt; 0,76 mg/l. Conclusiones: En los pacientes hipertensos, el factor más relacionado con los valores de cistatina C es la tasa de FG. El incremento de la cistatina C no es paralelo al incremento de la EUA</dc:description>
<dc:source>Med. clín (Ed. impr.);130(1): 1-5, ene. 2008. ilus, tab</dc:source>
<dc:identifier>ibc-058472</dc:identifier>
<dc:title xml:lang="es">Relación de la cistatina C con otros parámetros de riesgo vascular en pacientes con hipertensión arterial</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d422^s22016</dc:subject>
<dc:subject>^d2359^s22080</dc:subject>
<dc:subject>^d33939^s22045</dc:subject>
<dc:subject>^d24594^s22002</dc:subject>
<dc:subject>^d23568^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d22288^s22002</dc:subject>
<dc:subject>^d6063</dc:subject>
<dc:subject>^d28596</dc:subject>
<dc:type>article</dc:type>
<dc:date>200801</dc:date>
</metadata>
</record>
</ibecs-document>
